default search action

combined dblp search
author search
venue search
publication search

ask others

Dominik Schrahe

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Journal Articles

see FAQ

What is the meaning of the colors in the publication lists?

2024
[j4]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/sap/SchraheS24
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/sap/SchraheS24
Dominik Schrahe, Thomas Städter:
Privacy preserving vaccinating- and testing-pass for the European Union. Secur. Priv. 7(1) (2024)
2021
[j3]
- view
  authority control:
- export record
  dblp key:
  - journals/dud/SchraheS21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/dud/SchraheS21
Dominik Schrahe, Thomas Städter:
COVID-19-Impf- und -Testnachweise. Datenschutz und Datensicherheit 45(5): 315-319 (2021)
2020
[j2]
- view
  authority control:
- export record
  dblp key:
  - journals/dud/SchraheS20
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/dud/SchraheS20
Dominik Schrahe, Thomas Städter:
Gesundheits-Apps auf Rezept und Forschung mit Gesundheitsdaten. Datenschutz und Datensicherheit 44(11): 713-718 (2020)
2019
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/dud/SchraheS19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/dud/SchraheS19
Dominik Schrahe, Thomas Städter:
Integration von Informationssicherheits- und Datenschutzmanagement. Datenschutz und Datensicherheit 43(5): 265-269 (2019)

Coauthor Index

see FAQ

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.